Pharmalucence Announces FDA Approval For Use Of Sulfur Colloid Injection To Locate Ly

[News]

Pharmalucence, Inc. has received FDA approval expanding the route of administration and use of its Sulfur Colloid Injection (SCI) to include location of lymph nodes in breast cancer patients. Sulfur Colloid Injection (SCI) is a radioactive tracer manufactured by Pharmalucence which labels lymph nodes with a radioactive signal...

More... (http://www.medicalnewstoday.com/releases/231669.php)